Correction: Protection against N. gonorrhoeae induced by OMV-based meningococcal vaccines are associated with cross-species directed humoral and cellular immune responses

Affiliations

¹ Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
² Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
³ Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, United States.
⁴ Laboratory of Bacterial Polysaccharides, Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
⁵ Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States.
⁶ Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR, United States.
⁷ Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
⁸ Department of Medicine, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.

Published Erratum

Weiyan Zhu et al. Front Immunol. 2025.

. 2025 Sep 12:16:1697855.

doi: 10.3389/fimmu.2025.1697855. eCollection 2025.

¹ Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
² Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
³ Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, United States.
⁴ Laboratory of Bacterial Polysaccharides, Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
⁵ Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States.
⁶ Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR, United States.
⁷ Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
⁸ Department of Medicine, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1539795.].

Keywords: Neisseria gonorrhoeae; Neisseria meningitidis; correlates of protection; outer membrane vesicle (OMV); vaccine.

Protection against N. gonorrhoeae induced by OMV-based meningococcal vaccines are associated with cross-species directed humoral and cellular immune responses.
Zhu W, Waltmann A, Little MB, Connolly KL, Matthias KA, Thomas KS, Gray MC, Sikora AE, Criss AK, Bash MC, Macintyre AN, Jerse AE, Duncan JA. Zhu W, et al. Front Immunol. 2025 Apr 11;16:1539795. doi: 10.3389/fimmu.2025.1539795. eCollection 2025. Front Immunol. 2025. PMID: 40292302 Free PMC article.